Program review
Vyvron Review: 13 Charges a Year, Not 12
Vyvron bills every four weeks while printing a monthly price. At $199 that is $2,587 a year, not $2,388 — and tirzepatide has no monthly rung at all.
The short answer
Vyvron advertises weight-loss treatment "from $199/mo". Its own fine print says $199 per four weeks, billed every four weeks. Those are not the same product. Four-week billing means thirteen charges in a year, not twelve — $2,587 instead of $2,388, a $199 difference that appears nowhere on the page.
What's in this guide
The unit is wrong, and the unit is the whole story
A calendar year holds just over thirteen four-week cycles, which means thirteen billings in a typical year rather than twelve. So a program billed every four weeks at $199 costs $2,587 over twelve months, while a program billed monthly at $199 costs $2,388. Vyvron's terms describe the four-week cycle correctly and its marketing describes it as "/mo". Both appear on the same site.1
The extra $199 is not enormous on its own. It matters because it is invisible: nothing on the pricing card, nothing in the plan comparison, and nothing you would catch by reading the headline. If you are comparing Vyvron against a genuinely monthly program at the same sticker, the monthly one is $199 a year cheaper before either of you has done anything differently.
Tirzepatide cannot be bought by the month here
This is the finding that should decide it for most readers. Vyvron's weight-loss table has three tiers, and only the cheapest one is a recurring plan:
Start is $199 per four weeks, billed every four weeks, auto-renewing until canceled. It is semaglutide only, and it is the only recurring rung here.
Transform displays "$285/mo" and actually charges $790 once, for twelve weeks of tirzepatide.
Premium displays "$248/mo" and actually charges $2,981 once, for a full year of tirzepatide.
There is no monthly tirzepatide plan. The smallest tirzepatide purchase Vyvron will sell you is $790 up front. So we list no month-to-month tirzepatide price for Vyvron at all, rather than passing a prepaid plan off as a monthly rate.
Look closely at that "$285/mo" and it gets worse. $790 across twelve weeks is $285 only if you divide by about 2.77 calendar months. Divide by three four-week cycles — the unit Vyvron itself bills in — and it is $263. The same table is using two different definitions of "per month" in adjacent rows. And if you actually stayed on Transform, four consecutive twelve-week blocks cover 48 weeks and cost $3,160, against $2,981 for the annual plan that covers 52.
Founding rates, and a progress bar that never moves
Vyvron currently sells "founding member" pricing: $199 per four weeks for weight loss, $149 for microdosing, $189 for longevity. The list rates it says apply when founding closes are $249, $179 and $229.1 Individual longevity products are priced separately — injectable NAD+ and injectable sermorelin at $229, B12-MIC at $145.
Two things to know about the urgency. The homepage program cards and the program pages disagree: the cards say microdosing starts at $179 and longevity at $145, while the program pages say $149 and $189 per four weeks. We trust the program pages, because that is where the enrollment button and the billing disclosure live, and because the homepage's "$145" traces to the single cheapest longevity item rather than to the longevity program price. The homepage's microdosing figure is the post-founding list price displayed as though it were the current one.
And the counter reading "100 of 100 founding spots left" never changes: the number is fixed and the progress bar is always full. That is not a price defect, but it tells you what kind of urgency you are being sold.
What is genuinely good here
Clinical services run through OpenLoop Health and its affiliated professional entities — a real, substantial telehealth infrastructure company, named in the privacy policy. That is the strongest thing about Vyvron.
The state disclosure is unusually specific and deserves credit: all 50 states plus DC, with a video visit required in Arkansas, DC, Delaware, Kansas, Mississippi, New Mexico, Rhode Island and West Virginia, and compounded GLP-1 unavailable in Mississippi. Many sellers claim 50 states with no caveats, and some never name a state at all.
The testimonial section ships placeholders saying patient stories are coming once founding members give written consent. That is honest, and it is also an unambiguous statement that this company has no track record yet.
What is missing
No pharmacy is named. No prescriber is named. You are charged when you complete the intake — before a provider reviews it — with a full refund only if you cancel within 72 hours with no services rendered, or if a provider medically disqualifies you. Canceling a recurring plan requires 72 hours' notice before the next billing date or you are charged for that cycle anyway. Prepaid Transform and Premium plans refund only the months whose medication has not shipped.
The corporate entity is Vyvron, LLC at 30 N Gould St in Sheridan, Wyoming — the most heavily used registered-agent mail-drop address in the country, and not an operating location.
FDA warning letters
The FDA has issued no warning letter to Vyvron or its clinical partner (checked August 2026).2
The verdict for a bargain hunter
If you want semaglutide and you go in knowing you will be charged thirteen times a year, $199 per four weeks is a fair rung and Vyvron is a defensible pick. If you want tirzepatide, this is not a monthly program and should not be compared as one — the entry cost is $790 and you should be pricing it against the tirzepatide ranking, where several programs sell a real monthly rate. It is a milder version of the problem at the seller whose every membership is a six-month non-cancelable contract: in both cases the monthly figure on the card is a division, not a rung. Auren Rx publishes an explicit no-commitment tirzepatide price, $179 for a single month, which is the structure Vyvron is missing. And whatever you decide, the general defense against unit games like this one is in how to choose a GLP-1 provider without overpaying and the teaser-rate trap; the evidence behind the medicines is in our research library.
Frequently asked questions
How often does Vyvron actually bill you?
Every four weeks, which is thirteen charges a year rather than twelve, even though the marketing prints the price as a monthly rate. At the $199 rung that is $2,587 over twelve months instead of $2,388.
Can you buy Vyvron tirzepatide monthly?
No. There is no month-to-month tirzepatide plan. The cheapest tirzepatide purchase is $790 billed once for twelve weeks, and the annual plan is $2,981 billed once. The '$285/mo' shown on the twelve-week tier is that $790 divided out, not a rate you can pay.
Are Vyvron's founding-member prices real?
The rates are real — $199, $149 and $189 per four weeks against list rates of $249, $179 and $229. The scarcity is not: the 'spots left' counter never changes, and its progress bar is always full.
Does Vyvron name its pharmacy?
No, and no prescriber is named either. Clinical services run through OpenLoop Health, which is a real telehealth infrastructure company, but you are charged at intake before any provider reviews it.
References
- Vyvron, LLC (2026). Weight loss, microdosing and longevity program pricing. The company's own website
- U.S. Food and Drug Administration (2026). Warning Letters. FDA.gov. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Keep reading
Compounded Tirzepatide Cost: What You Actually Pay per Month
Compare compounded tirzepatide offers, ongoing monthly rates, dose increases and plan commitments. Advertised prices are not always comparable monthly bills.
Read the guideFoundayo (Orforglipron) Price: Every Dose, With and Without Insurance
Foundayo costs $149 to $349 a month cash by dose, as little as $25 with commercial coverage and Lilly's card, and $50 on Medicare's GLP-1 Bridge.
Read the guideDoes Insurance Cover Zepbound? Check the Plan Before the Price
Zepbound coverage depends on your plan, diagnosis and prior authorization. How to check your benefit, appeal a denial and compare the real pharmacy price.
Read the guideHow to Choose a GLP-1 Provider Without Overpaying
A savings-first checklist for picking a GLP-1 program: read the real 12-month price, verify the pharmacy, match the molecule, and skip teaser bait.
Read the guideThe Cheapest Legit Way to Start GLP-1 in 2026
Cash-pay GLP-1 starts under $99/mo in 2026 — but 'cheapest' only counts if it's legit. Here's how to get a low price from a verified pharmacy.
Read the guideHow to Spot a GLP-1 Teaser-Rate Trap
The $99-first-month-then-triples pattern is the most expensive GLP-1 trap. Here's how to spot the teaser rate and price the deal you'll actually pay.
Read the guide